News
WALDU
9.07
0.00%
0.00
Obagi Medical partners with ProMD Health in ALOHA Program to evaluate saypha MagIQ
Reuters · 03/19 12:29
Waldencast plc files initial beneficial ownership statement for CEO Michel Brousset
Reuters · 03/18 16:13
Waldencast plc files Form 3 initial beneficial ownership statement for director and 10% owner Cristiano Souza
Reuters · 03/18 15:26
Waldencast plc director Roberto Thompson Motta files initial beneficial ownership statement
Reuters · 03/18 15:24
Waldencast plc director Aaron Chatterley files initial beneficial ownership statement
Reuters · 03/18 14:34
Waldencast plc CFO Manuel Manfredi files initial beneficial ownership statement
Reuters · 03/18 14:32
Waldencast plc files Form 3 initial beneficial ownership statement for Chief Growth Officer Hind Sebti
Reuters · 03/18 14:28
Waldencast plc Director Brookie Kelly files initial beneficial ownership statement
Reuters · 03/18 14:26
UK’s Waldencast posts flat Q4 revenue on Milk Makeup weakness, withholds outlook
Reuters · 03/13 11:02
BRIEF-Waldencast Reports Fourth Quarter Results
Reuters · 03/13 10:58
BRIEF-Waldencast plc. Q4 Adjusted EBITDA USD 11 Million
Reuters · 03/13 10:50
Waldencast FY 2025 net loss widens to USD 248.06 million as adjusted EBITDA falls 60% to USD 16.07 million
Reuters · 03/13 10:47
Waldencast FY 2025 net loss widened 410% to USD 248.06 million, interest expense rose 46% to USD 25.09 million
Reuters · 03/13 10:47
Waldencast's Obagi and Schweiger Dermatology launch ALOHA Phase 4 study of saypha MagIQ injectable
Reuters · 02/27 13:33
OBAGI MEDICAL AND SCHWEIGER DERMATOLOGY ANNOUNCE COLLABORATION IN THE ALOHA PROGRAM TO DRIVE REAL-WORLD EVIDENCE FOR OBAGI® SAYPHA® MAGIQ™
Reuters · 02/27 13:33
Obagi Medical Partners With It’s a Secret Med Spa in ALOHA Program for saypha MagIQ
Reuters · 02/25 13:26
OBAGI MEDICAL AND IT’S A SECRET MED SPA ANNOUNCE COLLABORATION IN THE ALOHA PROGRAM TO DRIVE REAL-WORLD EVIDENCE FOR OBAGI® SAYPHA® MAGIQ™
Reuters · 02/25 13:26
Waldencast Partners with Aesthetic Record for Obagi ALOHA Program
Reuters · 02/17 13:28
OBAGI MEDICAL AND AESTHETIC RECORD ANNOUNCE COLLABORATION IN THE ALOHA PROGRAM TO DRIVE REAL-WORLD EVIDENCE FOR OBAGI® SAYPHA® MAGIQ™
Reuters · 02/17 13:28
Waldencast Partners with DermFx for Obagi ALOHA Program
Reuters · 02/06 13:27
More
Webull provides a variety of real-time WALDU stock news. You can receive the latest news about Waldencast Acquisition Corp through multiple platforms. This information may help you make smarter investment decisions.
About WALDU
Waldencast plc is a global multi-brand beauty and wellness platform. It is focused on developing, acquiring, accelerating, and scaling conscious and purpose-driven brands. Its segments include Obagi Medical and Milk Makeup. The Obagi Medical segment sells advanced skincare products backed by science and formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and to protect and enhance skin tone and texture. Its portfolio of medical-grade skincare with consumer-centric, in-office injectable procedures includes Saypha ChIQ, and MagIQ lines of injectable hyaluronic acid gels. The Milk Makeup segment consists of the business of Milk. Its Milk’s business activities include developing, marketing, and selling cosmetics, skincare, and other beauty products. Its Milk Makeup segment offers over 250 products through its United States Website www.MilkMakeup.com and retail partners include Sephora globally and Ulta Beauty in the United States.